PathActMarker: an R package for inferring pathway activity of complex diseases

Graphical abstract

References

[1] Drier Y, Sheffer M, Domany E . Pathway-based personalized analysis of cancer. Proceedings of the National Academy of Sciences of the United States of America, 2013, 110( 16): 6388–6393

[2] Liberzon A, Subramanian A, Pinchback R, Thorvaldsdóttir H, Tamayo P, Mesirov J P . Molecular signatures database (MSigDB) 3.0. Bioinformatics, 2011, 27( 12): 1739–1740

[3] Kanehisa M, Goto S. Kegg: kyoto encyclopedia of genes and genomes. Nucleic Acids Research, 2000, 28(1): 27–30

[4] Li X, Li M, Xiang J, Zhao Z, Shang X . SEPA: signaling entropy-based algorithm to evaluate personalized pathway activation for survival analysis on pan-cancer data. Bioinformatics, 2022, 38( 9): 2536–2543

[5] Hänzelmann S, Castelo R, Guinney J . GSVA: gene set variation analysis for microarray and RNA-Seq data. BMC Bioinformatics, 2013, 14: 7

[6] Barbie D A, Tamayo P, Boehm J S, Kim S Y, Moody S E, . . Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature, 2009, 462( 7269): 108–112

[7] Lee E, Chuang H Y, Kim J W, Ideker T, Lee D . Inferring pathway activity toward precise disease classification. PLoS Computational Biology, 2008, 4( 11): e1000217

[8] Tomfohr J, Lu J, Kepler T B . Pathway level analysis of gene expression using singular value decomposition. BMC Bioinformatics, 2005, 6: 225

[9] Mao W, Zaslavsky E, Hartmann B M, Sealfon S C, Chikina M . Pathway-level information extractor (PLIER) for gene expression data. Nature Methods, 2019, 16( 7): 607–610

[10] Su K, Yu Q, Shen R, Sun S Y, Moreno C S, Li X, Qin Z S . Pan-cancer analysis of pathway-based gene expression pattern at the individual level reveals biomarkers of clinical prognosis. Cell Reports Methods, 2021, 1( 4): 100050

Acknowledgements

This work was supported in part by the National Natural Science Foundation of China (Grant No. 62202383), Guangdong Basic and Applied Basic Research Foundation (No. 2024A1515012602), and the National Key Research and Development Program of China (No. 2022YFD1801200).

Competing interests

The authors declare that they have no competing interests of financial conflicts to disclose.

RIGHTS & PERMISSIONS

2025 Higher Education Press